Novartis (NVS) Stock Highlights

97.11 | +0.35%

2024-12-21 00:04:35

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Statistics

Range Today

96.06 97.58

Volume Today 1.55M

Range 1 Year

92.35 120.92

Volume 1 Year 331.68M

Range 3 Year

74.09 120.92

Volume 3 Year 1.38B

Range 10 Year

59.9731 120.92

Volume 10 Year 5.25B

Highlights

Market Capitalization 194.15B (large)

Floating Shares 1.91B

Current Price 97.11

Price To Earnings 16.78

Price To Revenue 4.24

Price To Book 4.48

Earnings Per Share 5.73

Dividend Yield 3.86%

Dividend Per Share 3.74

Payout Ratio 65.26%

Performance

Latest +0.35%

1 Month -5.54%

3 Months -16.74%

6 Months -7.21%

1 Year -1.05%

3 Years +13.61%

5 Years +3.03%

10 Years +13.76%

Benchmarks

Market Capitalization

5 / 14

Gross Profits

5 / 14

Total Revenue

5 / 14

Total Rank

3 / 14

Free Cashflow

2 / 14

Performance 5 years

7 / 14

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.